• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双激素人工胰腺减轻1型糖尿病碳水化合物计数负担的疗效:一项随机交叉试验。

Efficacy of dual-hormone artificial pancreas to alleviate the carbohydrate-counting burden of type 1 diabetes: A randomized crossover trial.

作者信息

Gingras V, Rabasa-Lhoret R, Messier V, Ladouceur M, Legault L, Haidar A

机构信息

Institut de recherches cliniques de Montréal, Montreal, Quebec, Canada; Department of nutrition, Université de Montréal, Montreal, Quebec, Canada.

Institut de recherches cliniques de Montréal, Montreal, Quebec, Canada; Department of nutrition, Université de Montréal, Montreal, Quebec, Canada; Montreal Diabetes Research Center (MDRC), Montreal, Quebec, Canada; Research Center of the Université de Montréal Hospital Center (CRCHUM), Montreal, Quebec, Canada; Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada.

出版信息

Diabetes Metab. 2016 Feb;42(1):47-54. doi: 10.1016/j.diabet.2015.05.001. Epub 2015 Jun 10.

DOI:10.1016/j.diabet.2015.05.001
PMID:26072052
Abstract

AIM

Carbohydrate-counting is a complex task for many patients with type 1 diabetes. This study examined whether an artificial pancreas, delivering insulin and glucagon based on glucose sensor readings, could alleviate the burden of carbohydrate-counting without degrading glucose control.

METHODS

Twelve adults were recruited into a randomized, three-way, crossover trial (ClinicalTrials.gov identifier No. NCT01930097). Participants were admitted on three occasions from 7AM to 9PM and consumed a low-carbohydrate breakfast (women: 30g; men: 50g), a medium-carbohydrate dinner (women: 50g; men: 70g) and a high-carbohydrate lunch (women: 90g; men: 120g). At each visit, glucose levels were randomly regulated by: (1) conventional pump therapy; (2) an artificial pancreas (AP) accompanied by prandial boluses, matching the meal's carbohydrate content based on insulin-to-carbohydrate ratios (AP with carbohydrate-counting); or (3) an AP accompanied by prandial boluses based on qualitative categorization (regular or large) of meal size (AP without carbohydrate-counting).

RESULTS

The AP without carbohydrate-counting achieved similar incremental AUC values compared with carbohydrate-counting after the low- (P=0.54) and medium- (P=0.38) carbohydrate meals, but yielded higher post-meal excursions after the high-carbohydrate meal (P=0.004). The AP with and without carbohydrate-counting yielded similar mean glucose levels (8.2±2.1mmol/L vs. 8.4±1.7mmol/L; P=0.52), and both strategies resulted in lower mean glucose compared with conventional pump therapy (9.6±2.0mmol/L; P=0.02 and P=0.03, respectively).

CONCLUSION

The AP with qualitative categorization of meal size could alleviate the burden of carbohydrate-counting without compromising glucose control, although more categories of meal sizes are probably needed to effectively control higher-carbohydrate meals.

摘要

目的

对许多1型糖尿病患者而言,计算碳水化合物含量是一项复杂的任务。本研究探讨了一种基于葡萄糖传感器读数输送胰岛素和胰高血糖素的人工胰腺是否能减轻计算碳水化合物含量的负担,同时又不影响血糖控制。

方法

招募了12名成年人参加一项随机、三臂交叉试验(ClinicalTrials.gov标识符:NCT01930097)。参与者在上午7点至晚上9点期间分三次入院,分别食用低碳水化合物早餐(女性:30克;男性:50克)、中等碳水化合物晚餐(女性:50克;男性:70克)和高碳水化合物午餐(女性:90克;男性:120克)。每次就诊时,血糖水平通过以下方式随机调节:(1)传统泵治疗;(2)人工胰腺(AP)并给予餐时大剂量胰岛素,根据胰岛素与碳水化合物的比例匹配餐食的碳水化合物含量(计算碳水化合物含量的AP);或(3)人工胰腺并根据餐量的定性分类(正常或大量)给予餐时大剂量胰岛素(不计算碳水化合物含量的AP)。

结果

不计算碳水化合物含量的AP在低碳水化合物餐(P=0.54)和中等碳水化合物餐(P=0.38)后与计算碳水化合物含量相比,获得了相似的增量AUC值,但在高碳水化合物餐后餐后血糖波动更高(P=0.004)。计算和不计算碳水化合物含量的AP产生的平均血糖水平相似(8.2±2.1毫摩尔/升对8.4±1.7毫摩尔/升;P=0.52),与传统泵治疗相比,两种策略均导致平均血糖更低(9.6±2.0毫摩尔/升;分别为P=0.02和P=0.03)。

结论

根据餐量进行定性分类的AP可以减轻计算碳水化合物含量的负担,同时不影响血糖控制,尽管可能需要更多的餐量类别来有效控制高碳水化合物餐。

相似文献

1
Efficacy of dual-hormone artificial pancreas to alleviate the carbohydrate-counting burden of type 1 diabetes: A randomized crossover trial.双激素人工胰腺减轻1型糖尿病碳水化合物计数负担的疗效:一项随机交叉试验。
Diabetes Metab. 2016 Feb;42(1):47-54. doi: 10.1016/j.diabet.2015.05.001. Epub 2015 Jun 10.
2
A Simplified Semiquantitative Meal Bolus Strategy Combined with Single- and Dual-Hormone Closed-Loop Delivery in Patients with Type 1 Diabetes: A Pilot Study.1 型糖尿病患者简化半定量餐食推注策略联合单激素和双激素闭环输送的初步研究。
Diabetes Technol Ther. 2016 Aug;18(8):464-71. doi: 10.1089/dia.2016.0043. Epub 2016 May 18.
3
Single- and Dual-Hormone Artificial Pancreas for Overnight Glucose Control in Type 1 Diabetes.用于1型糖尿病患者夜间血糖控制的单激素和双激素人工胰腺
J Clin Endocrinol Metab. 2016 Jan;101(1):214-23. doi: 10.1210/jc.2015-3003. Epub 2015 Nov 2.
4
The challenges of achieving postprandial glucose control using closed-loop systems in patients with type 1 diabetes.使用闭环系统实现 1 型糖尿病患者餐后血糖控制的挑战。
Diabetes Obes Metab. 2018 Feb;20(2):245-256. doi: 10.1111/dom.13052. Epub 2017 Aug 10.
5
Post-breakfast closed-loop glucose control is improved when accompanied with carbohydrate-matching bolus compared to weight-dependent bolus.与基于体重的推注相比,早餐后闭环血糖控制在伴有碳水化合物匹配推注时得到改善。
Diabetes Metab. 2014 Jun;40(3):211-4. doi: 10.1016/j.diabet.2013.12.001. Epub 2014 Mar 19.
6
Reducing the need for carbohydrate counting in type 1 diabetes using closed-loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non-inferiority, crossover pilot trial.使用闭环自动化胰岛素输送(人工胰腺)和恩格列净减少 1 型糖尿病患者对碳水化合物计数的需求:一项随机、对照、非劣效、交叉先导试验。
Diabetes Obes Metab. 2021 Jun;23(6):1272-1281. doi: 10.1111/dom.14335. Epub 2021 Feb 28.
7
Simple meal announcements and pramlintide delivery versus carbohydrate counting in type 1 diabetes with automated fast-acting insulin aspart delivery: a randomised crossover trial in Montreal, Canada.简化餐食告知与普兰林肽给药,与加拿大蒙特利尔的 1 型糖尿病患者应用自动化速效门冬胰岛素的碳水化合物计数法:一项随机交叉试验
Lancet Digit Health. 2024 Jul;6(7):e489-e499. doi: 10.1016/S2589-7500(24)00092-X.
8
Use of an artificial pancreas among adolescents for a missed snack bolus and an underestimated meal bolus.青少年使用人工胰腺处理遗漏的零食大剂量胰岛素注射和估计不足的餐时大剂量胰岛素注射情况。
Pediatr Diabetes. 2016 Feb;17(1):28-35. doi: 10.1111/pedi.12230. Epub 2014 Oct 27.
9
Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial.双激素人工胰腺、单激素人工胰腺或传统胰岛素泵治疗在儿童和青少年 1 型糖尿病患者中的门诊过夜血糖控制:一项开放标签、随机对照试验。
Lancet Diabetes Endocrinol. 2015 Aug;3(8):595-604. doi: 10.1016/S2213-8587(15)00141-2. Epub 2015 Jun 8.
10
Does meal-time insulin dosing based on fat-protein counting give positive results in postprandial glycaemic profile after a high protein-fat meal in adolescents with type 1 diabetes: a randomised controlled trial.基于脂肪-蛋白质计数的餐时胰岛素剂量调整是否会在青少年 1 型糖尿病患者高蛋白-高脂肪餐后的餐后血糖谱中产生积极结果:一项随机对照试验。
J Hum Nutr Diet. 2020 Jun;33(3):396-403. doi: 10.1111/jhn.12711. Epub 2019 Oct 24.

引用本文的文献

1
Efficacy of carbohydrate counting in people with type 1 and type 2 diabetes mellitus: a systematic review and meta-analysis.碳水化合物计数法对1型和2型糖尿病患者的疗效:一项系统评价和荟萃分析。
Diabetol Int. 2025 Apr 10;16(3):546-558. doi: 10.1007/s13340-025-00810-4. eCollection 2025 Jul.
2
Twelve-Month Follow-up from a Randomized Controlled Trial of Simplified Meal Announcement Versus Precise Carbohydrate Counting in Adolescents with Type 1 Diabetes Using the MiniMed™ 780G Advanced Hybrid Closed-Loop System.简化餐次告知与精准碳水化合物计数在使用 MiniMedTM 780G 先进混合闭环系统的 1 型糖尿病青少年中 12 个月的随机对照试验随访结果。
Diabetes Technol Ther. 2024 Mar;26(S3):76-83. doi: 10.1089/dia.2023.0429.
3
Strategically Playing with Fire: SGLT Inhibitors as Possible Adjunct to Closed-Loop Insulin Therapy.
战略性玩火:SGLT 抑制剂作为闭环胰岛素治疗的可能辅助手段。
J Diabetes Sci Technol. 2021 Nov;15(6):1232-1242. doi: 10.1177/19322968211035411. Epub 2021 Sep 24.
4
Adjunctive Therapies to Optimize Closed-loop Glucose Control.优化闭环血糖控制的辅助治疗。
J Diabetes Sci Technol. 2021 Nov;15(6):1243-1251. doi: 10.1177/19322968211032701. Epub 2021 Jul 27.
5
New closed-loop insulin systems.新型闭环胰岛素系统。
Diabetologia. 2021 May;64(5):1007-1015. doi: 10.1007/s00125-021-05391-w. Epub 2021 Feb 6.
6
Intraperitoneal and subcutaneous glucagon delivery in anaesthetized pigs: effects on circulating glucagon and glucose levels.麻醉猪的腹腔内和皮下给予胰高血糖素:对循环胰高血糖素和血糖水平的影响。
Sci Rep. 2020 Aug 13;10(1):13735. doi: 10.1038/s41598-020-70813-5.
7
Role of Glucagon in Automated Insulin Delivery.胰高血糖素在自动化胰岛素输送中的作用。
Endocrinol Metab Clin North Am. 2020 Mar;49(1):179-202. doi: 10.1016/j.ecl.2019.10.008. Epub 2019 Dec 10.
8
Artificial Pancreas: Evaluating the ARG Algorithm Without Meal Announcement.人工胰腺:在无进餐通知情况下评估ARG算法
J Diabetes Sci Technol. 2019 Nov;13(6):1035-1043. doi: 10.1177/1932296819864585. Epub 2019 Jul 24.
9
A Clinical Guide to Advanced Diabetes Devices and Closed-Loop Systems Using the CARES Paradigm.《使用CARES范式的先进糖尿病设备和闭环系统临床指南》
Diabetes Technol Ther. 2019 Aug;21(8):462-469. doi: 10.1089/dia.2019.0105. Epub 2019 May 29.
10
Artificial Pancreas: Clinical Study in Latin America Without Premeal Insulin Boluses.人工胰腺:拉丁美洲无需餐时胰岛素大剂量注射的临床研究。
J Diabetes Sci Technol. 2018 Sep;12(5):914-925. doi: 10.1177/1932296818786488. Epub 2018 Jul 12.